| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |